drugset

drugset / Trial / NCT05670470

A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial

NCT05670470 ↗

Phase 3 Completed 84 enrolled Taejoon Pharmaceutical Co., Ltd.

RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective randomized study compared with active control arm.

Timeline

Start: 2022-09-21
Primary completion: 2023-01-15
Completion: 2023-01-31

Publications

Jeon SR, Park SK, Yang DH, Cha JM. Comparison of a novel mini-oral sulfate tablet and the conventional oral sulfate tablet in bowel preparation for colonoscopy: a prospective, randomized, investigator-blinded, multicenter, non-inferior, phase 3 trial. J Gastroenterol. 2023 Nov;58(11):1114-1123. doi: 10.1007/s00535-023-02023-5. Epub 2023 Aug 5.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CTP0303	Unknown	—	—
Comparator	Orafang Tab	Unknown	—	—

Indications

No indication recorded.